A systematic review of the differences between trial-eligible and trial-ineligible patients in real-world populations
The data suggest a systemic exclusion of women, individuals without relevant risk factors, and those at increased risk of adverse events, but data are limited and heavily weighted towards cardiovascular trials which commonly recruit (and report on) cardiovascular comorbidities/risk factors.